Skip to main content
Banana Farmer logo
Banana Farmer
System Transmission

_

Top Signal
100#1 JOB
Activity
2184Ripe
+961 today
System
Live1m
Terminal Asset View
stockNASDAQ

BMRN

$58.51-0.95%

Biomarin Pharmaceutical Inc

Neutral
Official Site
Market value
24H Total Traded
Total supply
52-Week Range
Ripeness Index
Live Analysis Active

Company Mission

Biomarin Pharmaceutical creates medicines for rare genetic disorders that affect very few people. Their drugs treat conditions like enzyme deficiencies and metabolic diseases that often have no other treatments. They make money by selling these specialized medications to hospitals, clinics, and patients around the world through prescription sales.

BMR

Industry Context

Biotechnology companies develop treatments using biological processes. The sector has seen increased attention for rare disease drugs, which often receive special regulatory designations and pricing. Companies in this space are evaluated based on their drug pipelines and clinical trial results.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified
Asset Diagnostics

Technical Matrix

Scanning
56Matrix
Market Momentum
43.6Holding Steady
Trend Strength
25Active Setup

Momentum Engine

Ready
41
Velocity Score
StaticOptimal FlowMax Vel
Trading Activity
0.5xNormal Volume
Today's Change
-0.95%Live Performance

Social Frequency

Listening
20
Social Freq
0.3x
Normal Vol
X/Twitter Activity
0.3xStreaming
Reddit Buzz
0.0xSynced
System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

© 2026 Precision Engine
20Velocity
Live Sync

Social Intelligence Pulse.

Our engine is currently indexing BMRN across global social channels to detect early sentiment shifts and technical alignment.

XActive
RedditActive
WebActive

Signal Catalysts

Intelligence Narrative Connected

Updated 06:20 PM UTC
As-of 03-14-2026 18:04 UTC
Develops rare disease treatments and makes money by selling these specialized drugs to hospitals and pharmacies worldwide.
Monthly chart shows base formation near recent lows, suggesting a strong foundation for potential moves showing consolidation pattern.
Biotech sector showing renewed interest as rare disease treatments gain attention, with focus on regulatory approvals, suggesting regulatory.

Educational only. Not investment advice.

Precision Intelligence Model
Live Terminal Stream

Loading chart...

Loading chart...

Loading chart...

Loading chart...